Ablation Technologies Market worth $3.81 Billion by 2019, According to a New Study on ASDReports

Thursday 9 October 2014, Amsterdam

The report, now available on ASDReports, “Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019”analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

This report studies the global ablation technologies market over the forecast period of 2014 to 2019. The market is expected to reach ~$3.81 billion by 2019, at CAGR of 9.6% from 2014 to 2019.

Based on type of product, the global ablation technologies market is classified into seven major segments, namely, light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators. The light/laser ablators segment is further classified into excimer laser ablators (including ultraviolet B laser ablators) and cold laser ablators. The radiofrequency ablators market is categorized into temperature-controlled RF ablators, fluid-cooled RF ablators, and robotic catheter manipulation systems. Likewise, the electrical ablators market is categorized into argon plasma/beam coagulators, and irreversible electroporation ablators. The ultrasound ablators segment includes high-intensity focused ultrasound ablators, magnetic resonance guided focused ultrasound ablators, ultrasonic surgical ablation systems, and extracorporeal shockwave lithotripsy systems. Similarly, the cryoablation devices segment is categorized into three sub-segments, namely tissue contact probe ablators, tissue spray probe ablators, and epidermal and subcutaneous cryoablation systems.

On the basis of applications, the global ablation technologies market is divided into nine segments, namely, general surgical applications, cancer applications, cardiovascular applications, ophthalmological applications, gynecological applications, urological applications, orthopedic applications, cosmetic surgical applications, and others (fecal incontinence, psoriasis, tonsillectomy, port wine stains, and gastro-esophageal reflex disease).

A number of factors such as technological advancements, rising prevalence of cancer and cardiovascular diseases, and growing number of ablation procedures are driving the growth of the global ablation technologies market. On the other hand, factors such as product recalls, cost-containment initiatives taken by various governments, and ongoing healthcare reforms in the U.S. market are restricting the growth of the global ablation technologies market.

As of 2014, North America holds the largest share of the global ablation technologies market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of ~12.8% from 2014 to 2019. A number of factors, including rising government efforts to modernize existing healthcare infrastructure, growing popularity of ablation procedures, and increasing focus of global market players on developing countries, are stimulating the growth of the ablation technologies market in the Asia-Pacific region.

Covidien plc (Ireland), Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are the major players in the global ablation technologies market.